The article suggests that research challenging the evidence for ADHD drugs does not lead to changes without public campaigns.
Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.
Two new articles find that rates of ADHD diagnosis and stimulant prescription continue to rise all over the world.
New data shows that calls to US poison control centers have increased significantly for children taking stimulant ADHD drugs.
A new study finds that stimulant prescribing rates to children continue to rise despite the well-established evidence documenting overdiagnosis of ADHD and overprescription of stimulants.
Psychostimulant prescriptions have increased by 344% (from 2003 to 2015) for women of reproductive age (15-44 years old).
New evidence suggests that children on ADHD medication may have stunted growth initially but more rapid increases in body mass over time.